CTEPH
Dec 05, 2018
Breakthrough Device Designation granted to the AI Software for CTEPH
[caption id="attachment_3727" align="aligncenter" width="2322"] FDA[/caption]
Read More...
Dec 05, 2018
[caption id="attachment_3727" align="aligncenter" width="2322"] FDA[/caption]
Read More...
DAWNZERA’s EU Approval Strengthens the Hereditary Angioedema Treatment Landscape
Jan 30, 2026
Understanding Bone Densitometers: Technology, Applications, and Impact on Bone Health
Nov 04, 2025
Wireless Brain Sensors: Revolutionizing Neuroscience and Healthcare
Oct 28, 2025
The Dynamic Landscape of Myelofibrosis Treatment: A 2024 Perspective
Jun 10, 2024
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper